Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques LeLorier

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Arthritis and Rheumatism|May 29, 2007
Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib?Elham Rahme, Alan N Barkun, Youssef Toubouti, et al.
Molecular Diagnosis & Therapy|November 1, 2016
Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a StatinDominic Mitchell, Jason R Guertin, Ange Christelle Iliza, et al.
Pharmacoepidemiology and Drug Safety|June 27, 2015
Diagnostic accuracy of algorithms to identify hepatitis C status, AIDS status, alcohol consumption and illicit drug use among patients living with HIV in an administrative healthcare databaseMadeleine Durand, Yishu Wang, François Venne, et al.
Journal of Clinical Epidemiology|September 11, 2021
Domperidone increases harmful cardiac events in Parkinson's disease: A Bayesian re-analysis of an observational studyGisèle Nakhlé, James M Brophy, Christel Renoux, et al.
The Annals of Pharmacotherapy|May 15, 2008
Drug reimbursement policies in Canada--need for improved access to critical therapiesJacques LeLorier, Alan Bell, David J Bougher, et al.
Frontiers in Pharmacology|March 4, 2022
Sex Differences in the Patterns of Systemic Agent use Among Patients With Psoriasis: A Retrospective Cohort Study in Quebec, CanadaRaymond Milan, Jacques LeLorier, Marie-Josée Brouillette, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 25, 2007
Exploring patient demographic and clinical characteristics associated with lipid-lowering pharmacotherapy use in primary carePendar Farahani, Mitchell Levine, Kathryn Gaebel, et al.
The American Journal of Medicine|November 8, 2005
Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly populationElham Rahme, Denis Choquette, Michele Beaulieu, et al.
The Canadian Journal of Cardiology|September 18, 2010
Utilization patterns of extended-release niacin in Canada: analysis of an administrative claims databaseMarc Dorais, Diana Chirovsky, Baishali Ambegaonkar, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|May 15, 2009
Evidence and values: requirements for public reimbursement of drugs for rare diseases--a case study in oncologyMichael Drummond, Bill Evans, Jacques LeLorier, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Arthritis and Rheumatism|May 29, 2007
Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib?Elham Rahme, Alan N Barkun, Youssef Toubouti, et al.
Molecular Diagnosis & Therapy|November 1, 2016
Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a StatinDominic Mitchell, Jason R Guertin, Ange Christelle Iliza, et al.
Pharmacoepidemiology and Drug Safety|June 27, 2015
Diagnostic accuracy of algorithms to identify hepatitis C status, AIDS status, alcohol consumption and illicit drug use among patients living with HIV in an administrative healthcare databaseMadeleine Durand, Yishu Wang, François Venne, et al.
Journal of Clinical Epidemiology|September 11, 2021
Domperidone increases harmful cardiac events in Parkinson's disease: A Bayesian re-analysis of an observational studyGisèle Nakhlé, James M Brophy, Christel Renoux, et al.
The Annals of Pharmacotherapy|May 15, 2008
Drug reimbursement policies in Canada--need for improved access to critical therapiesJacques LeLorier, Alan Bell, David J Bougher, et al.
Frontiers in Pharmacology|March 4, 2022
Sex Differences in the Patterns of Systemic Agent use Among Patients With Psoriasis: A Retrospective Cohort Study in Quebec, CanadaRaymond Milan, Jacques LeLorier, Marie-Josée Brouillette, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 25, 2007
Exploring patient demographic and clinical characteristics associated with lipid-lowering pharmacotherapy use in primary carePendar Farahani, Mitchell Levine, Kathryn Gaebel, et al.
The American Journal of Medicine|November 8, 2005
Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly populationElham Rahme, Denis Choquette, Michele Beaulieu, et al.
The Canadian Journal of Cardiology|September 18, 2010
Utilization patterns of extended-release niacin in Canada: analysis of an administrative claims databaseMarc Dorais, Diana Chirovsky, Baishali Ambegaonkar, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|May 15, 2009
Evidence and values: requirements for public reimbursement of drugs for rare diseases--a case study in oncologyMichael Drummond, Bill Evans, Jacques LeLorier, et al.
Pageof 10